# BD expands U.S. manufacturing capacity for syringes, needles and IV catheters

BD announced additional investments in its U.S. manufacturing network, including new needle and syringe production lines in Connecticut and Nebraska, and plans for over $30 million in 2025 to expand IV line capacity in Utah. The company hired more than 215 employees.

- Type: Expansion
- Announced: 2025-01-15
- Where: Connecticut, Nebraska, Utah, United States
- Value: $30.0M
- Jobs: 215
- Status: under construction
- Capacity: more than 40 percent increase in safety-engineered injection devices, more than 50 percent increase in conventional syringes
- Products: syringes, needles, IV catheters
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Becton Dickinson & Co](https://endata.com/companies/20401.md)

## Sources

- [investors.bd.com](https://investors.bd.com/news-events/press-releases/detail/868/bd-boosts-u-s-manufacturing-of-critical-medical-devices), 2025-01-15: "Domestic manufacturing is crucial for ensuring a resilient supply of essential health care devices."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.